Oro Lab in the News

Oro Lab supports EB Research

Video Title Image

Tony interviewed about manufacturing autologous tissue stem cells by Dr. Russ Altman on Stanford's "Future of Everything"   March 20, 2019

Watch the Interview
ray and i
New Treatment Identified for Drug Resistant Basal Cell Carcinomas

February 5, 2018

Read Commentary
sm
2nd Annual Center for Definitive and Curative Medicine Symposium

February 27, 2018

"Innovations in the Pipeline to Curative Medicines"
See Program
SOM
Tony named Co-Director of the Stanford Child Health Research Institute

September 1, 2017

View Announcement
Dr Oro
Oro lab and EB iPS Consortium awarded $5M California Institute of Regenerative Medicine Grant for Innovative Skin Stem Cell Therapy

December 7, 2017

View Announcement
Annual Center
1st Annual Center for Definitive and Curative Medicine Symposium 

February 3, 2017

"Curing the Incurable through Definitive Medicine"
See the Symposium Agenda
SOM
Inside Stanford Medicine
"Stanford announces new Center for Definitive and Curative Medicine"

July 24, 2017

 

View Commentary
SOM

First Stanford Child X Conference April 2, 2015

Definitive Stem Cell & Gene Therapy for Child Health

Tony gives talk on the potential for autologous, genetically-corrected, induced pluripotent cell-derived tissue stem cells for genetic diseases like Epidermolysis bullosa

Watch Tony's ChildX interview Watch Tony's ChildX Talk
SOM
Inside Stanford Medicine
"Stanford’s lab for cell, gene medicine opens in Palo Alto"

September 6, 2016

 

View Commentary
SOM
Inside Stanford Medicine
"Skin tumors develop specific mutations to resist drug, researchers say"

March 9, 2015

View Commentary
cancer cell
Vismodegib Resistance in Basal Cell Carcinoma: Not a Smooth Fit

March 9, 2015

Read Commentary

Therapeutic Reprogramming for the Treatment of Epidermolysis Bullosa

a
Inside Stanford Medicine
"Blistering skin disease may be treatable with 'therapeutic reprogramming,' researchers say"

Nov 26, 2014

 

View Commentary
a
Medical News Today
"'Therapeutic reprogramming' may lead to treatment for epidermolysis bullosa, a blistering skin disease"

Dec 1, 2014

 

View Commentary

Identification of the Atypical Protein Kinase C in Tumor Resistance

a
Inside Stanford Medicine
"Discovery opens door to multipronged attack against common skin cancer, study shows"

Feb 27, 2013

 

View Commentary
dfdd
San Francisco Business Times
"Catching the Hedgehog: Stanford researchers uncover new way to block cancers"

Feb 27, 2013

 

View Commentary